Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,381 to 1,400 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An overview of kinase downregulators and recent advances in discovery approaches. | Signal Transduct Target Ther | 2021 | 34924565 | PubTator, text mining | PubMed |
| Gene-specific quantification of nascent transcription following targeted degradation of endogenous proteins in cultured cells. | STAR Protoc | 2021 | 34917979 | PubTator, text mining | PubMed |
| Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma. | Nat Commun | 2021 | 34916494 | PubTator, text mining | PubMed |
| Ligand Enabled Pd(II)-Catalyzed γ-C(sp3)-H Lactamization of Native Amides. | J Am Chem Soc | 2021 | 34914877 | PubTator, text mining | PubMed |
| Advances in therapeutic targets-related study on systemic lupus erythematosus. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2021 | 34911862 | PubTator, text mining | PubMed |
| Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes. | Neurooncol Adv | 2021 | 34901858 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase Ligands. | Molecules | 2021 | 34885822 | PubTator, text mining | PubMed |
| Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma. | Molecules | 2021 | 34885651 | PubTator, text mining | PubMed |
| Myeloma: A Lot of Progress, Still a Long Way to Go. | Cancers (Basel) | 2021 | 34885195 | PubTator, text mining | PubMed |
| Genome Instability in Multiple Myeloma: Facts and Factors. | Cancers (Basel) | 2021 | 34885058 | PubTator, text mining | PubMed |
| Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity. | Int J Mol Sci | 2021 | 34884662 | PubTator, text mining | PubMed |
| A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. | Nat Commun | 2021 | 34880227 | PubTator, text mining | PubMed |
| Molecular Strategies to Target Protein Aggregation in Huntington's Disease. | Front Mol Biosci | 2021 | 34869596 | PubTator, text mining | PubMed |
| Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function. | Front Cell Neurosci | 2021 | 34867205 | PubTator, text mining | PubMed |
| Differentiation therapy for myeloid malignancies: beyond cytotoxicity. | Blood Cancer J | 2021 | 34864823 | PubTator, text mining | PubMed |
| Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation. | Blood Cancer J | 2021 | 34864816 | PubTator, text mining | PubMed |
| Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6. | ACS Chem Biol | 2021 | 34860497 | PubTator, text mining | PubMed |
| Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders. | J Med Chem | 2021 | 34855399 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Cereblon-Interacting Small Molecules in Multiple Myeloma Therapy. | J Pers Med | 2021 | 34834536 | PubTator, text mining | PubMed |
| Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates. | Pharmaceuticals (Basel) | 2021 | 34832866 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=70